nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrapone—ABCC3—Conjugated Estrogens—osteoporosis	0.316	0.491	CbGbCtD
Metyrapone—CYP3A4—Estropipate—osteoporosis	0.0594	0.0922	CbGbCtD
Metyrapone—CYP3A4—Calcitriol—osteoporosis	0.0594	0.0922	CbGbCtD
Metyrapone—CYP3A4—Ergocalciferol—osteoporosis	0.0475	0.0737	CbGbCtD
Metyrapone—CYP3A4—Raloxifene—osteoporosis	0.0396	0.0615	CbGbCtD
Metyrapone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0383	0.0594	CbGbCtD
Metyrapone—CYP3A4—Cholecalciferol—osteoporosis	0.0306	0.0475	CbGbCtD
Metyrapone—CYP3A4—Conjugated Estrogens—osteoporosis	0.0281	0.0436	CbGbCtD
Metyrapone—CYP3A4—Estradiol—osteoporosis	0.0247	0.0383	CbGbCtD
Metyrapone—Hirsutism—Estropipate—osteoporosis	0.00681	0.0326	CcSEcCtD
Metyrapone—Dermatitis atopic—Ibandronate—osteoporosis	0.00513	0.0245	CcSEcCtD
Metyrapone—Endocrine disorder—Ibandronate—osteoporosis	0.00458	0.0219	CcSEcCtD
Metyrapone—Hirsutism—Conjugated Estrogens—osteoporosis	0.0045	0.0215	CcSEcCtD
Metyrapone—Dermatitis atopic—Risedronate—osteoporosis	0.00422	0.0202	CcSEcCtD
Metyrapone—Endocrine disorder—Risedronate—osteoporosis	0.00377	0.018	CcSEcCtD
Metyrapone—Hirsutism—Estradiol—osteoporosis	0.0036	0.0172	CcSEcCtD
Metyrapone—Pancytopenia—Etidronic acid—osteoporosis	0.00272	0.013	CcSEcCtD
Metyrapone—Endocrine disorder—Estradiol—osteoporosis	0.00252	0.0121	CcSEcCtD
Metyrapone—Abdominal discomfort—Estropipate—osteoporosis	0.00238	0.0114	CcSEcCtD
Metyrapone—Abdominal discomfort—Alendronate—osteoporosis	0.00234	0.0112	CcSEcCtD
Metyrapone—Hypertension—Ergocalciferol—osteoporosis	0.00232	0.0111	CcSEcCtD
Metyrapone—Hypotension—Calcium Acetate—osteoporosis	0.00232	0.0111	CcSEcCtD
Metyrapone—Abdominal discomfort—Ibandronate—osteoporosis	0.00228	0.0109	CcSEcCtD
Metyrapone—Pain—Calcium Acetate—osteoporosis	0.00213	0.0102	CcSEcCtD
Metyrapone—Alopecia—Etidronic acid—osteoporosis	0.00203	0.00971	CcSEcCtD
Metyrapone—Abdominal discomfort—Risedronate—osteoporosis	0.00188	0.009	CcSEcCtD
Metyrapone—Pain—Ergocalciferol—osteoporosis	0.00188	0.00898	CcSEcCtD
Metyrapone—Angiopathy—Estropipate—osteoporosis	0.0018	0.00863	CcSEcCtD
Metyrapone—Alopecia—Estropipate—osteoporosis	0.00176	0.0084	CcSEcCtD
Metyrapone—Angiopathy—Raloxifene—osteoporosis	0.00175	0.00836	CcSEcCtD
Metyrapone—Alopecia—Alendronate—osteoporosis	0.00173	0.00827	CcSEcCtD
Metyrapone—Angiopathy—Ibandronate—osteoporosis	0.00173	0.00827	CcSEcCtD
Metyrapone—Alopecia—Ibandronate—osteoporosis	0.00168	0.00806	CcSEcCtD
Metyrapone—Dizziness—Calcium Acetate—osteoporosis	0.00164	0.00786	CcSEcCtD
Metyrapone—Abdominal discomfort—Zoledronate—osteoporosis	0.00163	0.00781	CcSEcCtD
Metyrapone—Pancytopenia—Zoledronate—osteoporosis	0.00162	0.00774	CcSEcCtD
Metyrapone—Vomiting—Calcium Acetate—osteoporosis	0.00158	0.00756	CcSEcCtD
Metyrapone—Abdominal discomfort—Conjugated Estrogens—osteoporosis	0.00157	0.00752	CcSEcCtD
Metyrapone—CYP11B1—Endogenous sterols—POMC—osteoporosis	0.00157	0.0107	CbGpPWpGaD
Metyrapone—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—osteoporosis	0.00148	0.0101	CbGpPWpGaD
Metyrapone—Nausea—Calcium Acetate—osteoporosis	0.00148	0.00706	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.00146	0.007	CcSEcCtD
Metyrapone—Angiopathy—Ethinyl Estradiol—osteoporosis	0.00146	0.00699	CcSEcCtD
Metyrapone—Hypertension—Ibandronate—osteoporosis	0.00143	0.00685	CcSEcCtD
Metyrapone—Angiopathy—Risedronate—osteoporosis	0.00142	0.00682	CcSEcCtD
Metyrapone—Alopecia—Ethinyl Estradiol—osteoporosis	0.00142	0.00681	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.00142	0.00678	CcSEcCtD
Metyrapone—CYP11B2—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.00141	0.00956	CbGpPWpGaD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.0014	0.00671	CcSEcCtD
Metyrapone—Hypertension—Calcitriol—osteoporosis	0.0014	0.00671	CcSEcCtD
Metyrapone—CYP11B2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.00139	0.00943	CbGpPWpGaD
Metyrapone—Nervous system disorder—Estropipate—osteoporosis	0.00138	0.00662	CcSEcCtD
Metyrapone—Skin disorder—Estropipate—osteoporosis	0.00137	0.00656	CcSEcCtD
Metyrapone—CYP11B2—Metabolism of steroid hormones and vitamin D—POMC—osteoporosis	0.00136	0.00927	CbGpPWpGaD
Metyrapone—Angiopathy—Pamidronate—osteoporosis	0.00135	0.00648	CcSEcCtD
Metyrapone—Nervous system disorder—Raloxifene—osteoporosis	0.00134	0.00642	CcSEcCtD
Metyrapone—CYP11B2—ACE Inhibitor Pathway—TGFB1—osteoporosis	0.00134	0.00909	CbGpPWpGaD
Metyrapone—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00133	0.00638	CcSEcCtD
Metyrapone—Skin disorder—Raloxifene—osteoporosis	0.00133	0.00635	CcSEcCtD
Metyrapone—Nervous system disorder—Ibandronate—osteoporosis	0.00133	0.00635	CcSEcCtD
Metyrapone—Alopecia—Pamidronate—osteoporosis	0.00132	0.00631	CcSEcCtD
Metyrapone—Skin disorder—Ibandronate—osteoporosis	0.00131	0.00629	CcSEcCtD
Metyrapone—Nausea—Ergocalciferol—osteoporosis	0.0013	0.00624	CcSEcCtD
Metyrapone—Abdominal pain—Etidronic acid—osteoporosis	0.00129	0.00617	CcSEcCtD
Metyrapone—Skin disorder—Calcitriol—osteoporosis	0.00129	0.00616	CcSEcCtD
Metyrapone—Abdominal discomfort—Estradiol—osteoporosis	0.00126	0.00602	CcSEcCtD
Metyrapone—Angiopathy—Zoledronate—osteoporosis	0.00124	0.00592	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Estropipate—osteoporosis	0.00122	0.00583	CcSEcCtD
Metyrapone—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.00121	0.00824	CbGpPWpGaD
Metyrapone—Pain—Estropipate—osteoporosis	0.00121	0.00578	CcSEcCtD
Metyrapone—Alopecia—Zoledronate—osteoporosis	0.0012	0.00576	CcSEcCtD
Metyrapone—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.0012	0.00817	CbGpPWpGaD
Metyrapone—CYP11B1—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.0012	0.00813	CbGpPWpGaD
Metyrapone—Angiopathy—Conjugated Estrogens—osteoporosis	0.00119	0.0057	CcSEcCtD
Metyrapone—Pain—Alendronate—osteoporosis	0.00119	0.00569	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.00119	0.00567	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00118	0.00565	CcSEcCtD
Metyrapone—Hypertension—Risedronate—osteoporosis	0.00118	0.00565	CcSEcCtD
Metyrapone—CYP11B1—Metabolism of steroid hormones and vitamin D—POMC—osteoporosis	0.00118	0.00799	CbGpPWpGaD
Metyrapone—Pain—Raloxifene—osteoporosis	0.00117	0.00559	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00117	0.00559	CcSEcCtD
Metyrapone—Alopecia—Conjugated Estrogens—osteoporosis	0.00116	0.00555	CcSEcCtD
Metyrapone—Pain—Ibandronate—osteoporosis	0.00116	0.00554	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00116	0.00553	CcSEcCtD
Metyrapone—Gastrointestinal pain—Estropipate—osteoporosis	0.00115	0.00552	CcSEcCtD
Metyrapone—CYP11B2—Biological oxidations—CYP27A1—osteoporosis	0.00115	0.00784	CbGpPWpGaD
Metyrapone—CYP11B2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.00114	0.00775	CbGpPWpGaD
Metyrapone—CYP11B2—Metapathway biotransformation—CYP27A1—osteoporosis	0.00114	0.00773	CbGpPWpGaD
Metyrapone—Gastrointestinal pain—Alendronate—osteoporosis	0.00114	0.00544	CcSEcCtD
Metyrapone—Pain—Calcitriol—osteoporosis	0.00113	0.00542	CcSEcCtD
Metyrapone—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00112	0.00537	CcSEcCtD
Metyrapone—Hypertension—Pamidronate—osteoporosis	0.00112	0.00537	CcSEcCtD
Metyrapone—Gastrointestinal pain—Raloxifene—osteoporosis	0.00112	0.00535	CcSEcCtD
Metyrapone—Abdominal pain—Estropipate—osteoporosis	0.00112	0.00534	CcSEcCtD
Metyrapone—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00111	0.00532	CcSEcCtD
Metyrapone—Gastrointestinal pain—Ibandronate—osteoporosis	0.00111	0.0053	CcSEcCtD
Metyrapone—Abdominal pain—Alendronate—osteoporosis	0.0011	0.00526	CcSEcCtD
Metyrapone—Nervous system disorder—Risedronate—osteoporosis	0.00109	0.00523	CcSEcCtD
Metyrapone—Skin disorder—Risedronate—osteoporosis	0.00108	0.00518	CcSEcCtD
Metyrapone—Gastrointestinal pain—Calcitriol—osteoporosis	0.00108	0.00518	CcSEcCtD
Metyrapone—Abdominal pain—Raloxifene—osteoporosis	0.00108	0.00517	CcSEcCtD
Metyrapone—Abdominal pain—Ibandronate—osteoporosis	0.00107	0.00512	CcSEcCtD
Metyrapone—ABCC3—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.00106	0.00719	CbGpPWpGaD
Metyrapone—Abdominal pain—Calcitriol—osteoporosis	0.00105	0.00501	CcSEcCtD
Metyrapone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.00104	0.00707	CbGpPWpGaD
Metyrapone—Nervous system disorder—Pamidronate—osteoporosis	0.00104	0.00498	CcSEcCtD
Metyrapone—Vomiting—Etidronic acid—osteoporosis	0.00104	0.00496	CcSEcCtD
Metyrapone—CYP2A6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.00103	0.00698	CbGpPWpGaD
Metyrapone—Hypertension—Zoledronate—osteoporosis	0.00102	0.0049	CcSEcCtD
Metyrapone—Headache—Etidronic acid—osteoporosis	0.00102	0.00489	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.001	0.0048	CcSEcCtD
Metyrapone—CYP11B1—Biological oxidations—CYP27A1—osteoporosis	0.000994	0.00675	CbGpPWpGaD
Metyrapone—Hypotension—Pamidronate—osteoporosis	0.000991	0.00474	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000988	0.00473	CcSEcCtD
Metyrapone—CYP11B1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000983	0.00668	CbGpPWpGaD
Metyrapone—CYP11B1—Metapathway biotransformation—CYP27A1—osteoporosis	0.00098	0.00666	CbGpPWpGaD
Metyrapone—Nausea—Etidronic acid—osteoporosis	0.000969	0.00464	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000966	0.00462	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Risedronate—osteoporosis	0.000963	0.00461	CcSEcCtD
Metyrapone—Pain—Risedronate—osteoporosis	0.000954	0.00456	CcSEcCtD
Metyrapone—Angiopathy—Estradiol—osteoporosis	0.000953	0.00456	CcSEcCtD
Metyrapone—Nervous system disorder—Zoledronate—osteoporosis	0.00095	0.00455	CcSEcCtD
Metyrapone—Skin disorder—Zoledronate—osteoporosis	0.000941	0.0045	CcSEcCtD
Metyrapone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000936	0.00448	CcSEcCtD
Metyrapone—Dizziness—Estropipate—osteoporosis	0.000933	0.00447	CcSEcCtD
Metyrapone—Alopecia—Estradiol—osteoporosis	0.000929	0.00444	CcSEcCtD
Metyrapone—Dizziness—Alendronate—osteoporosis	0.000919	0.0044	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000916	0.00438	CcSEcCtD
Metyrapone—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000915	0.00438	CcSEcCtD
Metyrapone—Gastrointestinal pain—Risedronate—osteoporosis	0.000912	0.00436	CcSEcCtD
Metyrapone—Pain—Pamidronate—osteoporosis	0.000907	0.00434	CcSEcCtD
Metyrapone—Skin disorder—Conjugated Estrogens—osteoporosis	0.000906	0.00433	CcSEcCtD
Metyrapone—Hypotension—Zoledronate—osteoporosis	0.000905	0.00433	CcSEcCtD
Metyrapone—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000905	0.00433	CcSEcCtD
Metyrapone—Dizziness—Raloxifene—osteoporosis	0.000904	0.00433	CcSEcCtD
Metyrapone—Vomiting—Estropipate—osteoporosis	0.000898	0.00429	CcSEcCtD
Metyrapone—Dizziness—Ibandronate—osteoporosis	0.000895	0.00428	CcSEcCtD
Metyrapone—Headache—Estropipate—osteoporosis	0.000884	0.00423	CcSEcCtD
Metyrapone—Vomiting—Alendronate—osteoporosis	0.000884	0.00423	CcSEcCtD
Metyrapone—Abdominal pain—Risedronate—osteoporosis	0.000882	0.00422	CcSEcCtD
Metyrapone—Hypotension—Conjugated Estrogens—osteoporosis	0.000872	0.00417	CcSEcCtD
Metyrapone—Headache—Alendronate—osteoporosis	0.000871	0.00417	CcSEcCtD
Metyrapone—Vomiting—Raloxifene—osteoporosis	0.000869	0.00416	CcSEcCtD
Metyrapone—Gastrointestinal pain—Pamidronate—osteoporosis	0.000867	0.00415	CcSEcCtD
Metyrapone—Vomiting—Ibandronate—osteoporosis	0.000861	0.00412	CcSEcCtD
Metyrapone—Headache—Raloxifene—osteoporosis	0.000857	0.0041	CcSEcCtD
Metyrapone—Headache—Ibandronate—osteoporosis	0.000848	0.00406	CcSEcCtD
Metyrapone—CYP11B2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000845	0.00574	CbGpPWpGaD
Metyrapone—CYP2A6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000844	0.00573	CbGpPWpGaD
Metyrapone—Vomiting—Calcitriol—osteoporosis	0.000843	0.00403	CcSEcCtD
Metyrapone—Nausea—Estropipate—osteoporosis	0.000838	0.00401	CcSEcCtD
Metyrapone—Abdominal pain—Pamidronate—osteoporosis	0.000838	0.00401	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000836	0.004	CcSEcCtD
Metyrapone—Headache—Calcitriol—osteoporosis	0.00083	0.00397	CcSEcCtD
Metyrapone—Pain—Zoledronate—osteoporosis	0.000828	0.00396	CcSEcCtD
Metyrapone—Nausea—Alendronate—osteoporosis	0.000826	0.00395	CcSEcCtD
Metyrapone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000823	0.00559	CbGpPWpGaD
Metyrapone—Nausea—Raloxifene—osteoporosis	0.000812	0.00389	CcSEcCtD
Metyrapone—CYP2E1—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000812	0.00552	CbGpPWpGaD
Metyrapone—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000805	0.00385	CcSEcCtD
Metyrapone—Nausea—Ibandronate—osteoporosis	0.000804	0.00385	CcSEcCtD
Metyrapone—Pain—Conjugated Estrogens—osteoporosis	0.000798	0.00382	CcSEcCtD
Metyrapone—Gastrointestinal pain—Zoledronate—osteoporosis	0.000792	0.00379	CcSEcCtD
Metyrapone—Hypertension—Estradiol—osteoporosis	0.00079	0.00378	CcSEcCtD
Metyrapone—Nausea—Calcitriol—osteoporosis	0.000787	0.00377	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000773	0.0037	CcSEcCtD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000771	0.00524	CbGpPWpGaD
Metyrapone—Abdominal pain—Zoledronate—osteoporosis	0.000766	0.00366	CcSEcCtD
Metyrapone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000763	0.00365	CcSEcCtD
Metyrapone—Dizziness—Ethinyl Estradiol—osteoporosis	0.000757	0.00362	CcSEcCtD
Metyrapone—Dizziness—Risedronate—osteoporosis	0.000738	0.00353	CcSEcCtD
Metyrapone—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000737	0.00353	CcSEcCtD
Metyrapone—Nervous system disorder—Estradiol—osteoporosis	0.000732	0.0035	CcSEcCtD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000731	0.00497	CbGpPWpGaD
Metyrapone—CYP11B1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000729	0.00495	CbGpPWpGaD
Metyrapone—Vomiting—Ethinyl Estradiol—osteoporosis	0.000728	0.00348	CcSEcCtD
Metyrapone—Skin disorder—Estradiol—osteoporosis	0.000725	0.00347	CcSEcCtD
Metyrapone—Headache—Ethinyl Estradiol—osteoporosis	0.000717	0.00343	CcSEcCtD
Metyrapone—Vomiting—Risedronate—osteoporosis	0.000709	0.00339	CcSEcCtD
Metyrapone—Dizziness—Pamidronate—osteoporosis	0.000701	0.00336	CcSEcCtD
Metyrapone—Headache—Risedronate—osteoporosis	0.000699	0.00334	CcSEcCtD
Metyrapone—CYP11B2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000685	0.00466	CbGpPWpGaD
Metyrapone—Nausea—Ethinyl Estradiol—osteoporosis	0.00068	0.00325	CcSEcCtD
Metyrapone—Vomiting—Pamidronate—osteoporosis	0.000674	0.00323	CcSEcCtD
Metyrapone—CYP2E1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000667	0.00453	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000664	0.00451	CbGpPWpGaD
Metyrapone—Headache—Pamidronate—osteoporosis	0.000664	0.00318	CcSEcCtD
Metyrapone—CYP2A6—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.000663	0.0045	CbGpPWpGaD
Metyrapone—Nausea—Risedronate—osteoporosis	0.000663	0.00317	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Estradiol—osteoporosis	0.000644	0.00308	CcSEcCtD
Metyrapone—Dizziness—Zoledronate—osteoporosis	0.000641	0.00306	CcSEcCtD
Metyrapone—Pain—Estradiol—osteoporosis	0.000638	0.00305	CcSEcCtD
Metyrapone—Nausea—Pamidronate—osteoporosis	0.00063	0.00301	CcSEcCtD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.00063	0.00428	CbGpPWpGaD
Metyrapone—Dizziness—Conjugated Estrogens—osteoporosis	0.000617	0.00295	CcSEcCtD
Metyrapone—Vomiting—Zoledronate—osteoporosis	0.000616	0.00295	CcSEcCtD
Metyrapone—Gastrointestinal pain—Estradiol—osteoporosis	0.00061	0.00292	CcSEcCtD
Metyrapone—Headache—Zoledronate—osteoporosis	0.000607	0.0029	CcSEcCtD
Metyrapone—CYP11B2—Biological oxidations—CYP19A1—osteoporosis	0.000606	0.00412	CbGpPWpGaD
Metyrapone—CYP11B2—Metapathway biotransformation—CYP19A1—osteoporosis	0.000597	0.00406	CbGpPWpGaD
Metyrapone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000595	0.00404	CbGpPWpGaD
Metyrapone—Vomiting—Conjugated Estrogens—osteoporosis	0.000593	0.00284	CcSEcCtD
Metyrapone—CYP11B1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000591	0.00401	CbGpPWpGaD
Metyrapone—Abdominal pain—Estradiol—osteoporosis	0.00059	0.00282	CcSEcCtD
Metyrapone—Headache—Conjugated Estrogens—osteoporosis	0.000584	0.0028	CcSEcCtD
Metyrapone—Nausea—Zoledronate—osteoporosis	0.000575	0.00275	CcSEcCtD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000568	0.00386	CbGpPWpGaD
Metyrapone—Nausea—Conjugated Estrogens—osteoporosis	0.000554	0.00265	CcSEcCtD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000554	0.00376	CbGpPWpGaD
Metyrapone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000547	0.00372	CbGpPWpGaD
Metyrapone—CYP2A6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.00054	0.00367	CbGpPWpGaD
Metyrapone—CYP2E1—Tryptophan metabolism—CYP19A1—osteoporosis	0.000535	0.00363	CbGpPWpGaD
Metyrapone—CYP11B1—Biological oxidations—CYP19A1—osteoporosis	0.000522	0.00355	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—POMC—osteoporosis	0.000518	0.00352	CbGpPWpGaD
Metyrapone—CYP11B1—Metapathway biotransformation—CYP19A1—osteoporosis	0.000515	0.0035	CbGpPWpGaD
Metyrapone—Dizziness—Estradiol—osteoporosis	0.000494	0.00236	CcSEcCtD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.00049	0.00333	CbGpPWpGaD
Metyrapone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000481	0.00327	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000478	0.00325	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000477	0.00324	CbGpPWpGaD
Metyrapone—Vomiting—Estradiol—osteoporosis	0.000475	0.00227	CcSEcCtD
Metyrapone—Headache—Estradiol—osteoporosis	0.000468	0.00224	CcSEcCtD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000454	0.00308	CbGpPWpGaD
Metyrapone—CYP2A6—Biological oxidations—CYP27A1—osteoporosis	0.000448	0.00305	CbGpPWpGaD
Metyrapone—Nausea—Estradiol—osteoporosis	0.000443	0.00212	CcSEcCtD
Metyrapone—CYP2A6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000443	0.00301	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000443	0.00301	CbGpPWpGaD
Metyrapone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000432	0.00294	CbGpPWpGaD
Metyrapone—CYP2E1—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000426	0.0029	CbGpPWpGaD
Metyrapone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000382	0.00259	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000382	0.00259	CbGpPWpGaD
Metyrapone—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000377	0.00256	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000377	0.00256	CbGpPWpGaD
Metyrapone—CYP11B2—Biological oxidations—POMC—osteoporosis	0.000364	0.00247	CbGpPWpGaD
Metyrapone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.00036	0.00244	CbGpPWpGaD
Metyrapone—CYP2E1—Biological oxidations—CYP27A1—osteoporosis	0.000354	0.00241	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000353	0.0024	CbGpPWpGaD
Metyrapone—ABCC3—NRF2 pathway—AGER—osteoporosis	0.000351	0.00239	CbGpPWpGaD
Metyrapone—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.00035	0.00238	CbGpPWpGaD
Metyrapone—CYP2E1—Metapathway biotransformation—CYP27A1—osteoporosis	0.000349	0.00237	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000344	0.00234	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—FDPS—osteoporosis	0.000343	0.00233	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PKM—osteoporosis	0.000343	0.00233	CbGpPWpGaD
Metyrapone—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000329	0.00223	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—GPD2—osteoporosis	0.000326	0.00221	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PGLS—osteoporosis	0.000326	0.00221	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000324	0.0022	CbGpPWpGaD
Metyrapone—CYP11B1—Biological oxidations—POMC—osteoporosis	0.000314	0.00213	CbGpPWpGaD
Metyrapone—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000309	0.0021	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000299	0.00203	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—TGFB1—osteoporosis	0.000298	0.00203	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ATIC—osteoporosis	0.000298	0.00202	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PNP—osteoporosis	0.000298	0.00202	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PKM—osteoporosis	0.000296	0.00201	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—FDPS—osteoporosis	0.000296	0.00201	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—GPD2—osteoporosis	0.000281	0.00191	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PGLS—osteoporosis	0.000281	0.00191	CbGpPWpGaD
Metyrapone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000276	0.00188	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000275	0.00187	CbGpPWpGaD
Metyrapone—CYP2A6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000266	0.00181	CbGpPWpGaD
Metyrapone—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.00026	0.00176	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ATIC—osteoporosis	0.000257	0.00174	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PNP—osteoporosis	0.000257	0.00174	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—OXCT1—osteoporosis	0.000253	0.00172	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CA2—osteoporosis	0.000253	0.00172	CbGpPWpGaD
Metyrapone—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000248	0.00168	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—MGLL—osteoporosis	0.000247	0.00168	CbGpPWpGaD
Metyrapone—CYP2A6—Biological oxidations—CYP19A1—osteoporosis	0.000235	0.0016	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000234	0.00159	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000233	0.00158	CbGpPWpGaD
Metyrapone—CYP2A6—NRF2 pathway—AGER—osteoporosis	0.00022	0.0015	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CA2—osteoporosis	0.000218	0.00148	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—OXCT1—osteoporosis	0.000218	0.00148	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PKM—osteoporosis	0.000213	0.00145	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—FDPS—osteoporosis	0.000213	0.00145	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—MGLL—osteoporosis	0.000213	0.00144	CbGpPWpGaD
Metyrapone—CYP2E1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000211	0.00143	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—IDH2—osteoporosis	0.00021	0.00143	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PGLS—osteoporosis	0.000202	0.00137	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GPD2—osteoporosis	0.000202	0.00137	CbGpPWpGaD
Metyrapone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.0002	0.00136	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.0002	0.00136	CbGpPWpGaD
Metyrapone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000198	0.00134	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CYP27A1—osteoporosis	0.000197	0.00134	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ACP5—osteoporosis	0.000192	0.0013	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000189	0.00129	CbGpPWpGaD
Metyrapone—CYP2E1—Biological oxidations—CYP19A1—osteoporosis	0.000186	0.00126	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ATIC—osteoporosis	0.000185	0.00126	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PNP—osteoporosis	0.000185	0.00126	CbGpPWpGaD
Metyrapone—CYP2E1—Metapathway biotransformation—CYP19A1—osteoporosis	0.000184	0.00125	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—IDH2—osteoporosis	0.000181	0.00123	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—TPI1—osteoporosis	0.000178	0.00121	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CYP27A1—osteoporosis	0.00017	0.00115	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—P4HB—osteoporosis	0.000168	0.00114	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ACP5—osteoporosis	0.000165	0.00112	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—GAPDH—osteoporosis	0.000165	0.00112	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000164	0.00112	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000163	0.00111	CbGpPWpGaD
Metyrapone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000163	0.0011	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000162	0.0011	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—RAP1A—osteoporosis	0.00016	0.00109	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—OXCT1—osteoporosis	0.000157	0.00107	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CA2—osteoporosis	0.000157	0.00107	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—TPI1—osteoporosis	0.000154	0.00104	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—MGLL—osteoporosis	0.000153	0.00104	CbGpPWpGaD
Metyrapone—ABCC3—NRF2 pathway—TGFB1—osteoporosis	0.000149	0.00101	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—P4HB—osteoporosis	0.000145	0.000982	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000144	0.000981	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—GAPDH—osteoporosis	0.000142	0.000964	CbGpPWpGaD
Metyrapone—CYP2A6—Biological oxidations—POMC—osteoporosis	0.000142	0.000962	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.00014	0.00095	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—RAP1A—osteoporosis	0.000138	0.000939	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PKM—osteoporosis	0.000133	0.000907	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—FDPS—osteoporosis	0.000133	0.000907	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—IDH2—osteoporosis	0.00013	0.000884	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ENO1—osteoporosis	0.00013	0.000881	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PSMA5—osteoporosis	0.000128	0.000868	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PSMA2—osteoporosis	0.000128	0.000868	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GPD2—osteoporosis	0.000127	0.00086	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PGLS—osteoporosis	0.000127	0.00086	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CYP27A1—osteoporosis	0.000122	0.000832	CbGpPWpGaD
Metyrapone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.00012	0.000819	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.00012	0.000819	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ACP5—osteoporosis	0.000119	0.000809	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000118	0.000799	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ATIC—osteoporosis	0.000116	0.000786	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PNP—osteoporosis	0.000116	0.000786	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000112	0.000762	CbGpPWpGaD
Metyrapone—CYP2E1—Biological oxidations—POMC—osteoporosis	0.000112	0.00076	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ENO1—osteoporosis	0.000112	0.000759	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—TPI1—osteoporosis	0.000111	0.000752	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PSMA2—osteoporosis	0.00011	0.000748	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PSMA5—osteoporosis	0.00011	0.000748	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PKM—osteoporosis	0.000105	0.000717	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—FDPS—osteoporosis	0.000105	0.000717	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—P4HB—osteoporosis	0.000104	0.000707	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CYP19A1—osteoporosis	0.000104	0.000704	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GAPDH—osteoporosis	0.000102	0.000694	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PGLS—osteoporosis	0.0001	0.000679	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GPD2—osteoporosis	0.0001	0.000679	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—RAP1A—osteoporosis	9.95e-05	0.000676	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—OXCT1—osteoporosis	9.84e-05	0.000669	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CA2—osteoporosis	9.84e-05	0.000669	CbGpPWpGaD
Metyrapone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.77e-05	0.000664	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—MGLL—osteoporosis	9.59e-05	0.000652	CbGpPWpGaD
Metyrapone—CYP2A6—NRF2 pathway—TGFB1—osteoporosis	9.3e-05	0.000632	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ATIC—osteoporosis	9.15e-05	0.000621	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PNP—osteoporosis	9.15e-05	0.000621	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CYP19A1—osteoporosis	8.93e-05	0.000607	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8.68e-05	0.000589	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	8.63e-05	0.000587	CbGpPWpGaD
Metyrapone—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	8.52e-05	0.000579	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ADCY5—osteoporosis	8.46e-05	0.000575	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—GPX1—osteoporosis	8.44e-05	0.000573	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—IDH2—osteoporosis	8.15e-05	0.000554	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ENO1—osteoporosis	8.04e-05	0.000546	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PSMA2—osteoporosis	7.92e-05	0.000538	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PSMA5—osteoporosis	7.92e-05	0.000538	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—MTHFR—osteoporosis	7.79e-05	0.000529	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—OXCT1—osteoporosis	7.78e-05	0.000528	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CA2—osteoporosis	7.78e-05	0.000528	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYP27A1—osteoporosis	7.67e-05	0.000521	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—MGLL—osteoporosis	7.58e-05	0.000515	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ACP5—osteoporosis	7.46e-05	0.000507	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ADCY5—osteoporosis	7.29e-05	0.000496	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—GPX1—osteoporosis	7.27e-05	0.000494	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—TPI1—osteoporosis	6.93e-05	0.000471	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—MTHFR—osteoporosis	6.71e-05	0.000456	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—P4HB—osteoporosis	6.52e-05	0.000443	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—IDH2—osteoporosis	6.44e-05	0.000438	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CYP19A1—osteoporosis	6.43e-05	0.000437	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GAPDH—osteoporosis	6.4e-05	0.000435	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—RAP1A—osteoporosis	6.23e-05	0.000423	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—POMC—osteoporosis	6.23e-05	0.000423	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYP27A1—osteoporosis	6.06e-05	0.000412	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ACP5—osteoporosis	5.89e-05	0.0004	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—TPI1—osteoporosis	5.48e-05	0.000372	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—POMC—osteoporosis	5.37e-05	0.000365	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ADCY5—osteoporosis	5.25e-05	0.000357	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GPX1—osteoporosis	5.23e-05	0.000356	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—POMC—osteoporosis	5.19e-05	0.000353	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—P4HB—osteoporosis	5.15e-05	0.00035	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GAPDH—osteoporosis	5.06e-05	0.000344	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ENO1—osteoporosis	5.04e-05	0.000342	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PSMA2—osteoporosis	4.96e-05	0.000337	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PSMA5—osteoporosis	4.96e-05	0.000337	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—RAP1A—osteoporosis	4.92e-05	0.000335	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PKM—osteoporosis	4.89e-05	0.000333	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—FDPS—osteoporosis	4.89e-05	0.000333	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—MTHFR—osteoporosis	4.83e-05	0.000328	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PGLS—osteoporosis	4.64e-05	0.000315	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GPD2—osteoporosis	4.64e-05	0.000315	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ATIC—osteoporosis	4.24e-05	0.000288	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PNP—osteoporosis	4.24e-05	0.000288	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYP19A1—osteoporosis	4.03e-05	0.000274	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ENO1—osteoporosis	3.98e-05	0.00027	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PSMA5—osteoporosis	3.92e-05	0.000267	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PSMA2—osteoporosis	3.92e-05	0.000267	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—POMC—osteoporosis	3.86e-05	0.000263	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CA2—osteoporosis	3.61e-05	0.000245	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—OXCT1—osteoporosis	3.61e-05	0.000245	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—MGLL—osteoporosis	3.52e-05	0.000239	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ADCY5—osteoporosis	3.29e-05	0.000224	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GPX1—osteoporosis	3.28e-05	0.000223	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYP19A1—osteoporosis	3.18e-05	0.000216	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—MTHFR—osteoporosis	3.03e-05	0.000206	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—IDH2—osteoporosis	2.99e-05	0.000203	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.81e-05	0.000191	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ACP5—osteoporosis	2.73e-05	0.000186	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ADCY5—osteoporosis	2.6e-05	0.000177	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GPX1—osteoporosis	2.59e-05	0.000176	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—TPI1—osteoporosis	2.54e-05	0.000173	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—POMC—osteoporosis	2.42e-05	0.000164	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—MTHFR—osteoporosis	2.39e-05	0.000162	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—P4HB—osteoporosis	2.39e-05	0.000162	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GAPDH—osteoporosis	2.35e-05	0.000159	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—RAP1A—osteoporosis	2.28e-05	0.000155	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—POMC—osteoporosis	1.91e-05	0.00013	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ENO1—osteoporosis	1.85e-05	0.000125	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PSMA2—osteoporosis	1.82e-05	0.000124	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PSMA5—osteoporosis	1.82e-05	0.000124	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.48e-05	0.0001	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ADCY5—osteoporosis	1.21e-05	8.2e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GPX1—osteoporosis	1.2e-05	8.17e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—MTHFR—osteoporosis	1.11e-05	7.54e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—POMC—osteoporosis	8.87e-06	6.03e-05	CbGpPWpGaD
